Company / Cash per Share
Sagimet Biosciences Inc. Cash per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$7.25
FY2024
5-year range
$7.25 / $405.97
FY2023-FY2024
Trend
-98.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
7.25 in FY2024.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, cash per share decreased 98.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.25 | -98.2% |
| FY2023 | $405.97 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026